Diabetic retinopathy: a global epidemic.
作者信息
Das Arup
机构信息
Department of Surgery, Division of Ophthalmology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA.
出版信息
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):133-4. doi: 10.4103/0974-9233.154385.
Abstract
摘要
相似文献
1
Diabetic retinopathy: a global epidemic.糖尿病视网膜病变：一种全球性的流行病。
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):133-4. doi: 10.4103/0974-9233.154385.
2
[Research progress of anti-angiogenesis drug targets in diabetic retinopathy].
Zhonghua Yan Ke Za Zhi. 2014 Nov;50(11):871-6.
3
Pharmacologic therapy for diabetic retinopathy.糖尿病视网膜病变的药物治疗
Semin Ophthalmol. 2015 Jul;30(4):252-63. doi: 10.3109/08820538.2013.859280. Epub 2014 Feb 27.
4
Diabetic Retinopathy: Battling the Global Epidemic.糖尿病视网膜病变：对抗全球流行疾病
Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6669-6682. doi: 10.1167/iovs.16-21031.
5
Therapeutic revolution in the management of diabetic retinopathy.糖尿病视网膜病变治疗的革命性进展
Can J Ophthalmol. 2017 Nov;52 Suppl 1:S1-S2. doi: 10.1016/j.jcjo.2017.06.006. Epub 2017 Jul 26.
6
Diabetic retinopathy: Battling the global epidemic.糖尿病视网膜病变：对抗全球流行疾病
Indian J Ophthalmol. 2016 Jan;64(1):2-3. doi: 10.4103/0301-4738.178155.
7
Doseof intravitreal bevacizumab [Avastin] used as preoperative adjunct therapy for proliferative diabetic retinopathy.玻璃体内注射贝伐单抗[阿瓦斯汀]作为增殖性糖尿病视网膜病变术前辅助治疗的剂量。
Retina. 2011 Jan;31(1):192; author reply 192-4. doi: 10.1097/IAE.0b013e3181fbcebc.
8
Development of New Proliferative Diabetic Retinopathy in the BEVORDEX Trial.BEVORDEX试验中新发性增殖性糖尿病视网膜病变的发生情况。
Ophthalmol Retina. 2019 Mar;3(3):286-287. doi: 10.1016/j.oret.2018.10.010. Epub 2018 Oct 25.
9
Diabetic Retinopathy.糖尿病视网膜病变
Prim Care. 2015 Sep;42(3):451-64. doi: 10.1016/j.pop.2015.05.005.
10
Diabetic retinopathy: in need of multi-dimensional pharmacotherapy.糖尿病视网膜病变：需要多维药物治疗。
QJM. 2018 Mar 1;111(3):205-206. doi: 10.1093/qjmed/hcx247.
引用本文的文献
1
Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development.利用胰岛素和瘦素诱导的蛋白酪氨酸磷酸酶1B氧化进行治疗开发。
Nat Commun. 2018 Jan 18;9(1):283. doi: 10.1038/s41467-017-02252-2.
2
A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models.一种有效的、选择性的、口服生物可利用的蛋白酪氨酸磷酸酶 PTP1B 抑制剂可改善动物模型中的胰岛素和瘦素信号转导。
J Biol Chem. 2018 Feb 2;293(5):1517-1525. doi: 10.1074/jbc.C117.819110. Epub 2017 Dec 7.
本文引用的文献
1
Telemedicine in diabetic retinopathy: current status and future directions.糖尿病视网膜病变中的远程医疗：现状与未来方向。
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):174-8. doi: 10.4103/0974-9233.154391.
2
Novel pharmacotherapies in diabetic retinopathy.糖尿病视网膜病变的新型药物疗法。
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):164-73. doi: 10.4103/0974-9233.154389.
3
Recent developments in laser treatment of diabetic retinopathy.糖尿病视网膜病变激光治疗的最新进展。
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):157-63. doi: 10.4103/0974-9233.150633.
4
Diabetic retinopathy and systemic factors.糖尿病视网膜病变与全身因素
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):151-6. doi: 10.4103/0974-9233.154388.
5
Imaging in diabetic retinopathy.糖尿病视网膜病变的影像学检查
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):145-50. doi: 10.4103/0974-9233.151887.
6
Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.糖尿病视网膜病变的分子机制：潜在治疗靶点
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):135-44. doi: 10.4103/0974-9233.154386.
7
Telemedicine and eye examinations for diabetic retinopathy: a time to maximize real-world outcomes.远程医疗与糖尿病视网膜病变的眼部检查：是时候最大化现实世界中的治疗效果了。
JAMA Ophthalmol. 2015 May;133(5):525-6. doi: 10.1001/jamaophthalmol.2015.0333.
8
Diabetic retinopathy and inflammation: novel therapeutic targets.糖尿病视网膜病变与炎症：新的治疗靶点
Middle East Afr J Ophthalmol. 2012 Jan;19(1):52-9. doi: 10.4103/0974-9233.92116.
9
Effects of medical therapies on retinopathy progression in type 2 diabetes.医学治疗对 2 型糖尿病视网膜病变进展的影响。
N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Epub 2010 Jun 29.
Zotero 插件